JS Link

JS Link ROA

The Return on Assets (ROA) of JS Link (127120.KQ) as of Oct 26, 2026 is -13.37 %. In the previous year, Return on Assets (ROA) was -19.86 % — a change of -32.70% (higher).

ROA

-13.37 %

YoY

-32.70%

Last updated:

In 2025, JS Link's return on assets (ROA) was -13.37 %, a -32.70% increase from the -19.86 % ROA in the previous year.

The JS Link ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
-10.70 KRW
Jan 1, 2019
-50.65 KRW
Jan 1, 2020
-24.87 KRW
Jan 1, 2021
-12.43 KRW
Jan 1, 2022
-17.89 KRW
Jan 1, 2023
-14.44 KRW
Jan 1, 2024
-19.86 KRW
Jan 1, 2025
-13.37 KRW
The JS Link ROA history
YEARROAYoY
-13.37 %-32.70%
-19.86 %+37.56%
-14.44 %-19.27%
-17.89 %+43.85%
-12.43 %-50.00%
-24.87 %-50.90%
-50.65 %+373.24%
-10.70 %-894.63%
1.35 %-103.55%
-37.94 %+37.15%
-27.66 %+27.03%
-21.78 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

JS Link Stock analysis

What does JS Link do? DNA Link, Inc. generates revenue through its genomic analysis services and products. The company offers genome biomarkers excavation products via the enhanced genome integration system (EGIS) brand, which includes high-quality data products, genomic analysis interpretation, and molecular diagnostic kit production technologies. Additionally, DNA Link provides personal genome analysis services under the deoxyribonucleic acid personalized services (DNAGPS) brand, targeting individuals seeking personalized genetic insights. The primary customers for EGIS are healthcare providers and research institutions requiring integrated genomic and clinical data solutions, while DNAGPS serves individual consumers interested in personalized health information. The enhanced genome integration system (EGIS) brand focuses on delivering comprehensive genomic analysis and clinical information integration, catering to the needs of medical professionals and research organizations. DNAGPS targets individual users who want detailed personal genome reports. Both product lines leverage DNA Link's expertise in genomic analysis and molecular diagnostics, ensuring high-quality data and interpretation services. The company's revenue streams are driven by the sale of these branded products to their respective target segments. DNA Link's business model centers around two core product lines: EGIS for professional and institutional clients and DNAGPS for individual consumers. EGIS products are sold to healthcare providers and research institutions that require advanced genomic data analysis and molecular diagnostic solutions. DNAGPS services are marketed directly to consumers seeking personalized genetic information. The company's revenue is derived from the licensing and sale of these branded genomic analysis services and products, with no mention of additional revenue sources in the business description. JS Link is one of the most popular companies on Eulerpool.

ROA Details

Understanding JS Link's Return on Assets (ROA)

JS Link's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing JS Link's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider JS Link's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in JS Link’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about JS Link stock

Return on Assets (ROA) of JS Link is -13.37 % in 2025.

Return on Assets (ROA) of JS Link changed from -19.86 % to -13.37 %, representing a -32.70% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) JS Link since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s JS Link with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — JS Link

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — JS Link